Stock Earnings

Question 1

ANI Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、ANI Pharmaceuticals Incの総資産は$1,283で、純lossは$-20です。

Question 2

ANIPの主要な財務比率は何ですか？

Accepted Answer

ANI Pharmaceuticals Incの流動比率は1.5、純利益率は-3.25、1株当たり売上高は$31.78です。

Question 3

ANI Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

ANI Pharmaceuticals Inc largest revenue segment is Generics and Other, at a revenue of 320,034,000 in the most earnings release.For geography, United States is the primary market for ANI Pharmaceuticals Inc, at a revenue of 604,989,000.

Question 4

ANI Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、ANI Pharmaceuticals Incの純lossは$-20です。

Question 5

ANI Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、ANI Pharmaceuticals Incの負債は855です。

Question 6

ANI Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

ANI Pharmaceuticals Incの総発行済株式数は21.11株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	747	614	486	316	216	208
Revenue Growth (YoY)	11%	26%	54%	46%	4%	1%
Cost of Revenue	291	250	181	138	100	87
Gross Profit	456	364	305	177	115	121
Selling, General & Admin	307	249	161	124	84	65
Research & Development	53	44	34	22	11	16
Operating Expenses	433	361	257	207	143	125
Other Non Operating Income (Expenses)	-1	-4	0	0	-4	0
Pretax Income	-14	-22	19	-62	-56	-26
Income Tax Expense	-4	-3	1	-14	-13	-3
Net Income	-14	-20	15	-49	-42	-22
Net Income Growth	-135%	-233%	-131%	17%	91%	-467%
Shares Outstanding (Diluted)	20.3	19.31	18.19	16.3	12.6	12
Shares Change (YoY)	5%	6%	12%	28.99%	5%	0%
EPS (Diluted)	-0.7	-1.04	0.85	-3.05	-3.4	-1.88
EPS Growth	-133%	-222%	-128%	-10%	81%	-476%
Free Cash Flow	125	47	110	-40	0	9
Free Cash Flow Per Share	6.15	2.43	6.04	-2.45	0	0.75
Gross Margin	61.04%	59.28%	62.75%	56.01%	53.24%	58.17%
Operating Margin	2.94%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Profit Margin	-1.87%	-3.25%	3.08%	-15.5%	-19.44%	-10.57%
Free Cash Flow Margin	16.73%	7.65%	22.63%	-12.65%	0%	4.32%
EBITDA	106	69	107	30	20	40
EBITDA Margin	14.19%	11.23%	22.01%	9.49%	9.25%	19.23%
D&A For EBITDA	84	67	59	59	47	44
EBIT	22	2	48	-29	-27	-4
EBIT Margin	2.94%	0.32%	9.87%	-9.17%	-12.5%	-1.92%
Effective Tax Rate	28.57%	13.63%	5.26%	22.58%	23.21%	11.53%

ANI Pharmaceuticals Inc (ANIP) Price

ANIP Stock Price Chart

ANIP Income

Follow-Up Questions